Description
The NxTAG® CoV Extended Panel is a multiplex nucleic acid test that supports the high-throughput detection of SARS‑CoV‑2 in nasopharyngeal swab (NPS) samples. Designed for use on the NxTAG-Enabled MAGPIX® System, the NxTAG CoV panel detects three separate gene targets to ensure accurate, reliable results.
The NxTAG CoV Extended Panel offers:
Comprehensive Detection: Detect SARS‑CoV‑2 using three viral genes (ORF1ab, E gene, and N gene), enabling accurate, reliable results.
Rapid, Reliable Results: A highly scalable, cost-effective solution that can process up to 96 extracted samples in approximately 3 hours.
Flexible Testing Options: Run tests in any combination—use the NxTAG CoV panel as a standalone test to detect SARS‑CoV‑2, detect 20 other common respiratory pathogens with the NxTAG® Respiratory Pathogen Panel (RPP), or run both tests in parallel for a complete picture of a patient’s respiratory health.
